GSK, Theravance lung drug Relvar wins European green light

LONDON (Reuters) – GlaxoSmithKline and Theravance’s new inhaled lung drug Relvar has been recommended for approval in Europe, Britain’s biggest drugmaker said on Thursday. The green light from the European Medicines Agency follows approval for the product in May in the United States, where it is known as Breo. The medicine is inhaled through a palm-sized device called Ellipta. The drug consists of a corticosteroid to reduce inflammation and a novel long-acting beta-agonist (LABA), which is designed to open the airways. While the U.S. …

Mental disorder treatment common after childhood cancer

By Kathleen Raven NEW YORK (Reuters Health) – People who had cancer as children are more likely to be treated for neurodevelopmental, emotional or behavioral disorders later in life, a new Danish study finds. Researchers examined records from survivors’ siblings as well, finding those who were younger than 10 years old or not yet born when the cancer was diagnosed tended to also have higher risks of mental trouble later on. Programs designed especially for sibling mental health are quite rare, said lead author Dr. Lasse Lund of the Cancer Society Research Centre and University of Copenhagen. …

Syria war, refugees to cost Lebanon $7.5 billion: World Bank

Syrian refugee children eat fruits under a tent at the Majdal Anjar refugee camp in Bekaa Valley, eastern LebanonBy Dominic Evans BEIRUT (Reuters) – Syria's conflict will cost Lebanon $7.5 billion in cumulative economic losses by the end of next year, the World Bank has said in a report prepared for an aid meeting at the United Nations. A summary of the report, seen by Reuters after the World Bank briefed diplomats in Beirut, provides the most detailed assessment yet of the strain Syria's conflict has placed on its small Mediterranean neighbor. It estimates that the war and resulting wave of refugees into Lebanon will cut real GDP growth by 2. …

House Republicans ignore Obama veto threat on spending bill

Speaker of the House John Boehner speaks after meeting with U.S. President Obama in WashingtonBy Richard Cowan WASHINGTON (Reuters) – Republicans in the House of Representatives on Thursday plowed ahead with a bill to gut President Barack Obama's healthcare law while temporarily funding other government programs, ignoring a warning from the White House that the measure would be vetoed. The bill, which would keep the government running through December 15 and avert shutdowns with the start of the new fiscal year on October 1, faced its first test vote in the House on Thursday with passage of the measure expected on Friday. …

1 42 43 44 45 46 99